Three year survival among patients with aids-related Kaposi sarcoma treated with chemotherapy and combination antiretroviral therapy at Moi teaching and referral hospital, Kenya.
Naftali BusakhalaGabriel KigenPaul WaakoR Matthew StrotherFredrick ChitePatrick LoehrerPublished in: Infectious agents and cancer (2019)
Number PACTR201510001.
Keyphrases
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv infected patients
- hiv positive
- hiv aids
- primary care
- healthcare
- locally advanced
- medical students
- acute care
- free survival
- adverse drug
- squamous cell carcinoma
- emergency department
- newly diagnosed
- radiation therapy
- medical education
- chemotherapy induced
- rectal cancer